Purpose: The QA team of the Japan carbon-ion radiation oncology study group (J-CROS) was organized in 2015 to enhance confidence in the accuracy of clinical dosimetry and ensure that the facility QA procedures are adequate. The team conducted onsite dosimetry audits in all the carbon-ion radiation therapy centers in Japan.
(LET)), compared to proton and photon beams. Tsuji et al. reported that C-ion RT has clinical advantages over other modalities such as photon IMRT and proton RT. 2 However, the clinical results reported by most papers were from a limited number of centers. The Japan carbon-ion radiation oncology study group (J-CROS) was established in 2014 to obtain clinical evidence through a multicenter C-ion RT clinical trial. [3] [4] [5] Treatment comparability and consistency are crucial for meaningful trial results, particularly, for the absolute dose used in each center or the treatment planning process, from the point of view of medical physics. 6 Dosimetry audit systems have been established for clinical high-energy photon and electron beams [7] [8] [9] [10] ; however, there was no such audit system for C-ion RT, in Japan. In National protocol-based beam calibration and dose specification, (c)
Clear specification of the relative biological effectiveness (RBE) model, (d) QA for converting the CT number into the carbon-ion stopping power ratio, (e) Dose specification for the volume using the standard nomenclature for ICRU reports, [11] [12] [13] and (f) Assessment of the patient anatomical and physiological changes during a fraction or over the course of treatment. All these items were checked before credentialing a center for participating in the clinical trials. In the onsite audits, dosimetry audits were performed to assure dose consistency between centers. This paper describes the methodology for external dosimetry audits in carbon facilities, and presents the results of the first round of audits using this methodology.
| MATERIALS AND METHODS

2.A | Phantom system
A phantom was designed for performing the onsite dosimetry audit, which involved CT acquisition, treatment planning, position alignment, and ionization dosimetry. The phantom had to be designed such that it can be transported, and accurate dose measurements within a short duration, using ionization chambers, should be possi- ionization chamber followed the IAEA TRS-398 definition. 14 The alignment jig included iron balls such that it can be seen in the CT images used for planning as well as the x-ray images used in the treatment room for patient-position alignment.
2.B | Treatment planning
Two plans, one using a high-energy beam and the other using low energy, were used in each center. The actual incident beam energies were approximately 400 and 290 MeV/u, respectively (MeV/u is MeV per nucleon). The isocenter was set to geometric depths of 16.3 and 7.3 cm from the beam entry point. A scribe line identifies the insertion position of the alignment jig at the isocenter depth.
The alignment jig has iron balls arranged in a row, corresponding to the beam line. By defining an isocenter on the central iron ball, the planner can easily create a treatment plan with a fixed isocenter.
The planner was asked to generate a 3-cm-diameter circle gross target volume (GTV) in the isocenter slice and copy it to a length of 3 cm, along the superior-inferior (SI) axis. The margins of the clinical target volume (CTV), internal target volume (ITV), and planning target volume (PTV) were 10 mm (3D), 4 mm (SI direction), and 5 mm (3D), respectively. The prescribed dose was 4 Gy (RBE) at the isocenter;
95% of the prescribed dose should cover the PTV. For calculating the dose distribution, the stopping power ratio of water/PMMA was assigned to the inside or wall of the phantom, respectively. Figure 2 shows a treatment plan, using these criteria.
2.C | Dosimetry
The phantom was sent to the center several weeks before the onsite audit. CT images were obtained and treatment plans (for high-and low-energy planning) were created using the same methodology as that used for the patients. The J-CROS QA team then visited the center with a calibrated dosimeter, thermometer, and barometer.
The same tools were used in all the audits conducted in this study. | 33 set up and alignment of the phantom was performed by local radiation technologists, similar to that for a patient. Alignment was carried out using 2D-based procedures with orthogonal x-ray images and DRR images, for all the centers. The precision of the setup was verified using a line marker on the outside wall of the phantom, which corresponded to the correct position of the ionization chamber. All the centers could successfully locate the phantom in the correct position within a precision of 1 mm. After aligning the phantom, the alignment jig was removed, and a chamber holder equipped with the ionization chamber was inserted (Fig. 3) . Carbon-ion beam irradiation was performed, according to the irradiation parameters determined by the treatment planning system. To check the reproducibility, the same irradiation was repeated several times. The reading of the ionization chamber was converted into the absorbed dose using the Japanese reference dosimetry code of practice (standard dosimetry of the absorbed dose to water in external beam radiotherapy), 15 based on the IAEA TRS 398. The obtained dose data were compared with the output of the physical dose treatment plan. All five centers that had performed C-ion RT in Japan, in 2016, participated in this dosimetry audit.
| RESULTS
3.A | Facility specifications
The general data obtained from the questionnaire, including the beam specifications, treatment planning system, and the reference dosimeters used in the center are summarized in Table 1 .
Most items were equivalent in all the centers, including the maximum field size, maximum range of the treatment beam (excluding one center), and the procedure for converting the CT value into the stopping power ratio. The maximum range of the treatment beam is valid for a specific field size, such as a beam with a diameter of 10 cm and not necessarily the maximum field size. 
3.B | Dosimetry results
The obtained results are shown in Table 2 . The average of the percentage ratio between the measured and calculated doses (measured/calculated) was 0.5% (−2.7% to +2.6%) and the standard deviation, 1.7%. Currently, there is no established agreement criteria between the measured and calculated absorbed doses for passive and scanning C-ion beams. The European organization for research and treatment of cancer-radiation oncology group (EORTCROG) has adopted 3% as the optimal limit for the beam output audit of photon and electron beams. 16 Abletinger et al. 17 suggested that the mean value of the deviation between the measured and calculated doses should be less than 3%, while the maximum deviation should be less than 5% for the target volume in a homogeneous medium, in the dosimetry auditing of light-ion beam therapy. In this case, the tolerance level was set within 3%. All the beams of all the centers were within this tolerance level.
| DISCUSSION
The results were satisfactory because none of the beams exceeded the tolerance levels. This audit has demonstrated that the dose at a single point in the water phantom is within tolerance; it is a big step to say that all the doses are correct. In addition, this external audit has encouraged the centers to improve the quality of their dosimetry systems.
Center C improved the dosimetry accuracy, based on the results of this test. The thermometer and barometer had not been calibrated because they were mounted on an irradiation system and could not be easily calibrated independently; however, they were finally calibrated with traceability to the national standards.
This altered the reference dose by approximately 0.8%, resulting in a decrease in the difference between the measured and calculated doses, in the test results of this study. The corrected results of center C were +0.6% and +0.4% for plans 1 and 2, respectively.
In center E, where the difference in plan 1 exceeded 2%, an oldtype ionization chamber (TN23343, PTW-Freiburg, Freiburg, Germany) was used as the reference dosimeter. This reference
Photograph of the dosimetry with an ionization chamber. The ionization chamber was inserted into the phantom, corresponding to the marked IC position.
dosimeter was updated to a new type (TN34045, PTW-Freiburg), based on the results of this test. According to the measurement results, the absolute dose varied from +(0.6-0.9)%, depending upon the irradiation conditions. Using the average value of +0.7%, the corrected results of center E were −2.0% and −0.7%, respectively.
In view of the above, it is established that dose auditing improves the quality of the dose precision applied in clinical trial.
In external dosimetry audits, there are several reports in the case of conventional RT, such as photon therapy; however, they are rarely reported for particle beam therapy, particularly for C-ion RT.
Ableitinger et al. 17 reported end-to-end testing by the mailing method, using alanine dosimeters. However, in the case of alanine dosimeters, the dose rate and LET effects of the scanning beam must be considered, when analyzing the detector response. In addition, it is difficult to perform at a dose equivalent to the protocol defined for a multicenter clinical trial. As the alanine dosimeter requires a dose irradiation of 10 Gy or more for good reproducibility, it is not suitable for the verification of the treatment plan, for credentialing. As there are five C-ion RT centers in Japan, it is possible to perform onsite dosimetry audit; auditing can be done using One of the five participating centers operates both passive and scanning beam facilities; the test result of the scanning beam of the center was tabulated as an independent facility. ionization-chamber dosimetry, which is a high-precision standard dosimetry tool. Hence, in this study, we adopted a tolerance criterion of 3% and succeeded in assuring precise dosage.
In addition to physical dose matching, the RBE is another important value to be checked, among the centers participating in the clinical trials for C-ion RT. Using the treatment planning system of each center, the calculated RBE values for different conditions such as the incident beam energy, depth, and prescription dose were compared.
The detailed description of the results is not within the scope of this work; however, the results were comparable for all the centers.
| CONCLUSION
The J-CROS QA team conducted onsite dosimetry audits at all the C-ion RT centers in Japan. The audits were performed using two treatment plans, and the results were within the tolerance levels (<±3%), for all the centers. The activities of this QA team will continue and will be applied to new treatment centers in Japan, where C-ion RT is initiated.
